Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression-Reference-Cited by-同舟云学术

Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression

Published:2018-06-03 Issue:3 Volume:36 Page:576-583
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Junge Alexandra¹,Bacher Ulrike²,Mueller Beatrice U.³,Keller Peter²⁴,Solenthaler Max²⁵,Pabst Thomas¹^ORCID

Affiliation:

1. Department of Medical Oncology; Inselspital, University Hospital Bern, University of Bern; Switzerland

2. Department of Hematology; Inselspital, University Hospital Bern, University of Bern; Switzerland

3. Department of Biomedical Research; Inselspital, University Hospital Bern, University of Bern; Switzerland

4. Department of Hematology; Regionalspital; Langenthal Switzerland

5. Department of Hematology; Regionalspital; Thun Switzerland

Funder

Krebsliga Schweiz

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2516/fullpdf

Reference41 articles.

1. Acute myeloid leukemia: epidemiology and etiology;Deschler;Cancer,2006

2. Acute myeloid leukemia;Döhner;N Engl J Med,2015

3. European Group for the Immunological Characterization of leukemia (EGIL), proposals for the immunological classification of acute leukemias;Bene;Leukemia,1995

4. Modern diagnostics in acute leukemias;Haferlach;Crit Rev Onc/Hemat,2005

5. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy;Jennings;Blood,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis;Scientific Reports;2021-09-09

2. miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia;Oncogene;2021-04-22

3. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56;International Journal of Laboratory Hematology;2021-03-11

4. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group;Modern Pathology;2021-02-01

5. Fc gamma receptor expression serves as prognostic and diagnostic factor in AML;Leukemia & Lymphoma;2020-06-16